The Summary of Benefits and Coverage remains the most underutilized analytical tool in employer health plan evaluation. Despite being federally mandated since 2012 under 45 CFR 147.200 and designed specifically for standardized plan comparison, the SBC is routinely bypassed in favor of broker summaries and carrier marketing materials. Kaiser Family Foundation's 2025 Employer Health Benefits Survey data indicates that fewer than 35% of employers with under 200 employees report conducting detailed SBC analysis before making plan decisions. The remaining 65% are making their largest recurring benefits expenditure based on incomplete information.
This analysis provides a systematic framework for extracting actionable intelligence from the SBC document, identifies the specific data points that drive the largest cost differentials between ostensibly similar plans, and quantifies the financial impact of SBC-informed decision-making versus premium-only evaluation. The framework is designed for benefits managers, CFOs, and brokers who need to evaluate plan value beyond surface-level cost metrics.
The core premise is straightforward: two plans with identical premiums and identical deductibles can produce annual cost differentials of $1,200 to $2,400 per covered employee when analyzed through the SBC's standardized coverage examples and cost-sharing structures. For a 50-employee group, that translates to $60,000 to $120,000 in undetected cost variation that premium comparison alone cannot reveal.
Key Takeaways
- The SBC's two standardized coverage examples (Type 2 Diabetes management and Normal Delivery) use HHS-defined utilization assumptions, enabling actuarially consistent cross-plan comparison that no other disclosure document provides.
- Out-of-pocket maximum differential, not deductible differential, is the primary driver of catastrophic cost exposure, with 2026 federal limits at $9,450/$18,900 (individual/family).
- Copay vs. coinsurance structure in the Common Medical Events table creates cost variance of 40-120% for identical service utilization patterns, particularly in specialist and imaging categories.
- Pharmacy tier architecture accounts for 28-33% of total plan spending (Mercer 2025), yet SBC pharmacy sections are the least-analyzed component in employer plan evaluation.
- The Excluded Services section generates 60%+ of employee benefit complaints (SHRM 2024), and pre-enrollment review eliminates the highest-impact satisfaction drivers.
- SBC-informed plan selection produces measurable outcomes: 8-15% reduction in total cost of coverage when employers use coverage examples as the primary comparison metric rather than premium alone.
Regulatory Framework and SBC Structure
The SBC was established under Section 2715 of the Public Health Service Act, as added by Section 1001 of the Affordable Care Act. The implementing regulations at 45 CFR 147.200 specify both the content requirements and the standardized template that all group health plans and insurance issuers must follow. The Department of Labor, HHS, and the Treasury Department jointly administer enforcement.
The standardized 8-page format contains the following analytical components:
| SBC Section | Pages | Analytical Value | Common Analysis Gap |
|---|---|---|---|
| Plan Identification | 1 | Coverage period alignment, network type classification | Coverage period mismatch between renewal SBC and current year SBC |
| Important Questions Grid | 1 | Deductible, OOP max, services before deductible, separate deductibles | Aggregate vs. embedded family deductible distinction not analyzed |
| Common Medical Events | 2-3 | Service-level cost-sharing, copay vs. coinsurance, prior auth requirements | Coinsurance variability vs. copay predictability not quantified |
| Coverage Examples | 4 | Standardized utilization-based cost modeling (diabetes, maternity) | Most employers skip this section entirely; it is the highest-value comparison tool |
| Excluded Services | 5-6 | Coverage gaps, employee satisfaction predictors | Not reviewed pre-enrollment; drives majority of post-enrollment complaints |
| Rights and Notices | 7-8 | Minimum essential coverage, minimum value determination | ACA compliance verification often deferred to broker without independent check |
The Coverage Examples: Actuarial Comparison in Practice
The SBC's two mandated coverage examples use HHS-defined utilization patterns to generate standardized cost projections. These examples assume specific service frequencies, provider types, and drug utilization that are held constant across all plans. This standardization makes the coverage examples the only true apples-to-apples comparison available in the insurance marketplace.
The Type 2 Diabetes management example assumes annual utilization including physician office visits, lab work, and prescription medications at frequencies defined by HHS. The Normal Delivery (maternity) example assumes prenatal care, hospital delivery, and postnatal follow-up. Both examples calculate the patient's total estimated annual cost under each plan's specific cost-sharing rules.
The data reveals significant inter-plan variance:
| Metric | Plan A (PPO, $2,000 ded.) | Plan B (EPO, $2,000 ded.) | Plan C (HMO, $1,500 ded.) | Variance Range |
|---|---|---|---|---|
| Diabetes Example Cost | $5,400 | $3,800 | $3,200 | $2,200 (69%) |
| Maternity Example Cost | $4,200 | $3,100 | $2,800 | $1,400 (50%) |
| Premium (PEPM) | $680 | $695 | $640 | $55 (8%) |
| Total Cost of Coverage (Premium + OOP) | $13,560 | $12,240 | $10,880 | $2,680 (25%) |
The data demonstrates a critical finding: premium variance across these three plans is only 8%, but total cost of coverage variance is 25%. Premium-only analysis would incorrectly identify Plan C (HMO) as the cheapest option by $55/month, when in fact the total value differential is $223/month. The coverage examples expose this gap; premium analysis alone cannot.
Copay vs. Coinsurance: Quantifying Cost Predictability
The Common Medical Events table in the SBC distinguishes between copay-based and coinsurance-based cost-sharing. This distinction has measurable financial implications that most plan evaluations fail to quantify.
A copay creates a fixed, predictable cost per service. A $40 specialist copay means the employee pays $40 regardless of the billed amount. Coinsurance creates variable cost exposure tied to the provider's charge. A 30% coinsurance for a specialist visit means the employee pays $90 on a $300 charge but $210 on a $700 charge.
For employers analyzing population-level cost exposure, the coinsurance model introduces actuarial variance that copay models eliminate. BLS data on specialist visit charges shows a standard deviation of $180-$320 depending on specialty, meaning coinsurance-based plans create unpredictable employee cost exposure even for routine utilization.
The practical impact is measurable in employee satisfaction and retention data. SHRM's 2024 Employee Benefits Survey found that employees in copay-based plans report 22% higher satisfaction with their health benefits than employees in coinsurance-based plans with equivalent actuarial value. The predictability premium is real and quantifiable.
Pharmacy Tier Architecture Analysis
Pharmacy represents the fastest-growing component of employer health plan costs, accounting for 28-33% of total spending in Mercer's 2025 National Survey data. The SBC's pharmacy section reveals the tier structure but not the formulary composition. However, the tier cost-sharing structure alone provides significant analytical signal.
Key analytical indicators in the pharmacy section:
| Indicator | What It Reveals | Financial Impact |
|---|---|---|
| Generic copay above $25 | Plan has aggressive pharmacy cost-shifting to employees | $60-$180/year per employee on maintenance medications |
| Specialty tier uses coinsurance | Catastrophic pharmacy exposure for employees on biologics | $5,000-$30,000/year per affected employee (GLP-1, biologics, oncology) |
| Separate pharmacy deductible | Total deductible exposure exceeds stated medical deductible | $250-$500 additional deductible exposure not captured in headline deductible comparison |
| 4-tier vs. 5-tier formulary | 5-tier formularies typically separate preferred specialty from non-preferred specialty | 20-40% cost differential on specialty medications depending on tier placement |
The GLP-1 medication class has made pharmacy tier analysis particularly urgent. With monthly costs of $800-$1,500 per patient for drugs like Ozempic, Wegovy, and Mounjaro, the difference between a $250 copay and 30% coinsurance on a $1,200/month drug is $110/month ($1,320/year) per affected employee. For employers with 5-10% GLP-1 utilization rates (consistent with EBRI 2025 projections for blue-collar industries), this single formulary decision can shift $6,600-$13,200 annually in costs between employer and employee.
Network Type Impact on Total Cost of Coverage
The SBC identifies network type (HMO, PPO, EPO, POS), but the cost implications extend beyond the premium differential. KFF 2025 data shows the following average cost relationships:
| Network Type | Avg. Annual Premium (Single) | Avg. Deductible | OON Coverage | Balance Billing Exposure |
|---|---|---|---|---|
| HMO | $7,680-$8,400 | $1,500-$2,500 | Emergency only | Minimal (network-only model) |
| EPO | $8,100-$9,000 | $1,800-$3,000 | Emergency only | Minimal (no OON except emergency) |
| PPO | $9,000-$10,800 | $1,500-$3,500 | Yes, at higher cost | Significant (allowed amount vs. billed charges) |
| POS | $8,400-$9,600 | $1,500-$2,800 | With referral | Moderate (referral-gated OON access) |
A critical analytical point: PPO plans show the widest premium range but also introduce balance billing exposure that is not captured in the out-of-pocket maximum. When a PPO plan uses "allowed amount" (typically 150-250% of Medicare rates) as the reimbursement basis for out-of-network services, the difference between the allowed amount and the provider's billed charges falls to the employee and is not subject to the OOP maximum. This creates uncapped cost exposure that the SBC discloses but that most plan comparisons fail to quantify.
The No Surprises Act (effective January 2022) provides some protection for emergency services and certain non-emergency services at in-network facilities, but it does not eliminate balance billing for elective out-of-network care. For employers with distributed workforces who may utilize out-of-network providers more frequently, this exposure is material.
Excluded Services: The Leading Indicator of Employee Dissatisfaction
SHRM's 2024 Employee Benefits Survey data indicates that benefits-related employee complaints correlate most strongly with excluded services, not with deductible levels or premium contributions. The most frequently excluded services in small group insurance plans, and their complaint frequency, follow a predictable pattern:
- Infertility treatment: Excluded on approximately 60% of small group plans outside of state-mandated coverage states. High emotional and financial impact ($15,000-$25,000 per IVF cycle).
- Bariatric surgery: Excluded on approximately 40% of small group plans. With obesity rates exceeding 40% nationally (CDC 2024), this exclusion affects a significant portion of the workforce.
- Hearing aids (adult): Excluded on approximately 50% of plans. Average cost of hearing aids is $2,000-$7,000 per pair.
- Gender-affirming care: Exclusion rates vary significantly by carrier and state. Legal landscape is evolving rapidly.
- Applied Behavioral Analysis (ABA) for autism: Mandated in most states but excluded on some self-funded ERISA plans that are exempt from state mandates.
For benefits managers conducting plan evaluations, the excluded services section should be analyzed against the employer's workforce demographics. An employer with a young, predominantly female workforce should prioritize maternity and fertility coverage analysis. An employer with an older workforce should focus on hearing, vision, and chronic condition management exclusions.
Advanced SBC Analytics: Balance Billing, Prior Authorization, and Preventive Care Classification
Balance Billing Exposure Quantification
The SBC discloses whether the plan uses "allowed amount" or "billed charges" for out-of-network reimbursement. Plans using allowed amount at 150% of Medicare create predictable balance billing exposure. For a hip replacement with a Medicare rate of $12,000, the allowed amount would be $18,000. If the OON provider charges $45,000, the employee faces $27,000 in balance billing not subject to the OOP maximum. This single data point in the SBC can reveal exposure of $10,000-$50,000 per incident for common surgical procedures.
Prior Authorization Burden Analysis
The SBC identifies which services require prior authorization. The AMA's 2024 Prior Authorization Physician Survey reports that 94% of physicians say prior authorization delays necessary care, with average delays of 2-5 business days for standard requests and 5-14 days for peer-to-peer reviews. Plans with extensive prior authorization requirements create measurable friction in care delivery. For employers, this translates to lost productivity (employees managing authorization processes) and potential clinical deterioration (delayed treatment).
Preventive vs. Diagnostic Classification
ACA-compliant plans must cover preventive services at zero cost-sharing. However, the boundary between "preventive" and "diagnostic" is where significant cost variation hides. The colonoscopy reclassification issue is the most well-documented example: a screening colonoscopy is preventive (no cost), but if a polyp is found and removed, approximately 30-40% of insurance plans reclassify the procedure as diagnostic and apply the deductible. This reclassification can shift $1,500-$3,000 to the employee for a procedure they were told was "free."
The Consolidated Appropriations Act of 2023 addressed this specific issue for colonoscopies with polyp removal, requiring plans to cover them as preventive regardless of findings. However, similar classification ambiguities exist for other screenings (mammograms that lead to biopsy, PSA tests that lead to additional testing), and these are not uniformly resolved across all insurance plans.
Benefits Savings Strategy Builder
Model plan design changes across deductible, copay, coinsurance, and network type variables to quantify total cost of coverage differentials. No login required. Free.
Mental Health Parity Compliance via SBC Analysis
The Mental Health Parity and Addiction Equity Act (MHPAEA), as strengthened by the Consolidated Appropriations Act of 2021 and the 2024 final rule, requires that financial requirements (copays, deductibles, coinsurance) and quantitative treatment limitations (visit limits, day limits) for mental health and substance use disorder benefits be no more restrictive than those for medical/surgical benefits.
The SBC provides a direct parity check. Compare:
- Office visit copay for primary care vs. mental health outpatient
- Inpatient day limits for medical/surgical vs. mental health/substance use
- Prior authorization requirements for medical/surgical vs. mental health services
- Out-of-network cost-sharing for medical vs. behavioral health
If the SBC shows a $40 copay for a primary care visit but $75 for a mental health outpatient visit, this is a potential parity violation. The 2024 MHPAEA final rule strengthened enforcement by requiring plans to conduct comparative analyses demonstrating parity in both quantitative and non-quantitative treatment limitations (NQTLs). Employers who identify potential parity violations through SBC analysis can request the plan's NQTL comparative analysis to verify compliance.
SBC-Informed Plan Selection: Quantified Outcomes
A 30-employee professional services firm in Maryland evaluated three renewal options using the SBC coverage example methodology rather than premium-only comparison. The results:
| Metric | Option A (Lowest Premium) | Option B (Mid Premium) | Option C (Selected) |
|---|---|---|---|
| Annual Premium (30 EEs) | $237,600 | $248,400 | $252,000 |
| SBC Diabetes Example (per patient) | $6,100 | $4,200 | $3,900 |
| Est. Total OOP (30 EEs, avg. utilization) | $68,000 | $42,000 | $36,000 |
| Total Cost of Coverage | $305,600 | $290,400 | $288,000 |
| Premium-Only Ranking | 1st (cheapest) | 2nd | 3rd (most expensive) |
| Total Cost Ranking | 3rd (most expensive) | 2nd | 1st (cheapest) |
The premium-only analysis would have selected Option A, which was the most expensive plan when total cost of coverage was calculated. The SBC coverage examples inverted the ranking entirely. The employer selected Option C, saving $17,600 in total cost of coverage while simultaneously improving employee cost predictability (copay-based vs. coinsurance-based structure).
Post-implementation, the employer's next annual benefits satisfaction survey showed an 18-point increase in employee satisfaction with health benefits. Voluntary turnover attributable to benefits dissatisfaction (measured via exit interviews) decreased from 3 employees to 0 over the following 12 months.
Frequently Asked Questions
How do the SBC coverage examples calculate patient costs?
HHS defines standardized utilization assumptions for each example (service frequencies, drug quantities, provider types). These assumptions are applied to each plan's specific cost-sharing structure (deductible, copays, coinsurance, OOP max) to generate the estimated annual patient cost. Because the utilization assumptions are identical across all plans, the resulting cost figures are directly comparable.
What is the difference between an embedded and aggregate family deductible?
An embedded family deductible allows individual family members to satisfy their own deductible threshold (typically the individual deductible amount) without waiting for the entire family deductible to be met. An aggregate family deductible requires the full family deductible to be satisfied before any family member receives post-deductible coverage. For a family of four, the aggregate model can delay coverage by months compared to the embedded model. The SBC should specify this, but the language is often ambiguous.
How does balance billing interact with the out-of-pocket maximum?
Balance billing amounts (the difference between the provider's charge and the plan's allowed amount for out-of-network services) are not subject to the out-of-pocket maximum. This means an employee could reach their $9,450 OOP maximum and still face $20,000+ in balance billing charges from a single out-of-network surgical episode. The No Surprises Act provides protection for emergency services and certain ancillary services at in-network facilities, but does not cover elective out-of-network care.
What penalty applies for failure to distribute the SBC?
The Department of Labor can assess penalties of up to $1,363 per failure (2026 adjusted amount) for willful failure to provide the SBC. Each participant or beneficiary who does not receive a timely SBC constitutes a separate failure. Additionally, employees can sue for the SBC under ERISA Section 502(c), which allows courts to impose up to $110 per day until the SBC is provided.
Can the SBC be used to identify MHPAEA parity violations?
Yes. The SBC provides a first-pass parity check by comparing financial requirements (copays, coinsurance, deductibles) for mental health/substance use services against medical/surgical services. If the SBC shows higher cost-sharing for mental health services than for comparable medical/surgical services, this is a potential quantitative parity violation. Non-quantitative treatment limitation (NQTL) analysis requires the plan's separate comparative analysis document.
How should self-funded employers approach SBC analysis differently than fully insured employers?
Self-funded employers have greater flexibility to modify plan design based on SBC analysis findings. If the SBC reveals suboptimal pharmacy tier structures or excessive prior authorization requirements, a self-funded employer can direct the TPA to adjust these parameters. Fully insured employers must choose among the carrier's available plan designs. Self-funded employers should also verify that the SBC accurately reflects any plan amendments or rider modifications made during the plan year.
References
- Kaiser Family Foundation. "2025 Employer Health Benefits Survey." KFF.org, October 2025.
- U.S. Department of Health and Human Services. "Summary of Benefits and Coverage and Uniform Glossary." 45 CFR 147.200.
- Society for Human Resource Management. "2024 Employee Benefits Survey: Benefits Decision-Making Practices." SHRM.org, June 2024.
- Mercer. "National Survey of Employer-Sponsored Health Plans 2025." Mercer.com, November 2025.
- American Medical Association. "2024 Prior Authorization Physician Survey." AMA-assn.org, January 2024.
- Employee Benefit Research Institute. "GLP-1 Medication Utilization Projections for Employer Health Plans." EBRI.org, 2025.
- Bureau of Labor Statistics. "Employer Costs for Employee Compensation." BLS.gov, March 2026.
- Centers for Disease Control and Prevention. "Adult Obesity Prevalence Maps." CDC.gov, September 2024.
- U.S. Department of Labor. "Mental Health Parity and Addiction Equity Act Final Rule." DOL.gov, September 2024.
- Congressional Research Service. "No Surprises Act: Implementation and Enforcement." CRS.gov, updated 2025.
About the Author
Sam Newland, CFP® has spent 13+ years in employee benefits consulting, helping small and mid-size employers navigate health plan decisions, funding strategies, and compliance requirements. As founder of PEO4YOU and Business Insurance Health, Sam specializes in translating complex benefits data into actionable decisions that save employers money and improve employee satisfaction.
